These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8682653)

  • 41. The role of oxidized LDL in atherosclerosis.
    Witztum JL
    Adv Exp Med Biol; 1991; 285():353-65. PubMed ID: 1858567
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunological response to oxidized LDL.
    Witztum JL
    Atherosclerosis; 1997 Jun; 131 Suppl():S9-11. PubMed ID: 9253468
    [No Abstract]   [Full Text] [Related]  

  • 43. Oxidized low-density lipoprotein, a two-faced Janus in coronary artery disease?
    Parthasarathy S; Santanam N; Augé N
    Biochem Pharmacol; 1998 Aug; 56(3):279-84. PubMed ID: 9744562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility of low-density lipoprotein to oxidative modification.
    Witztum JL
    Am J Med; 1993 Apr; 94(4):347-9. PubMed ID: 8475927
    [No Abstract]   [Full Text] [Related]  

  • 45. Low-density lipoprotein particle composition: what is the contribution to atherogenicity?
    Rudel LL; Kesäniemi YA
    Curr Opin Lipidol; 2000 Jun; 11(3):227-8. PubMed ID: 10882336
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of oxidized LDL in atherogenesis: immunological response and anti-phospholipid antibodies.
    Witztum JL; Hörkkö S
    Ann N Y Acad Sci; 1997 Apr; 811():88-96; discussion 96-9. PubMed ID: 9186588
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of oxidized LDL in the atherogenic process.
    Witztum JL
    J Atheroscler Thromb; 1994; 1(2):71-5. PubMed ID: 9222872
    [No Abstract]   [Full Text] [Related]  

  • 48. Novel atherogenic, oxidative modification of low-density lipoprotein.
    Parthasarathy S
    Diabetes Metab Rev; 1991 Sep; 7(3):163-71. PubMed ID: 1817001
    [No Abstract]   [Full Text] [Related]  

  • 49. The macrophage and its role in atherogenesis.
    Yokode M; Kita T
    Intern Med; 1995 Apr; 34(4):281-3. PubMed ID: 7606100
    [No Abstract]   [Full Text] [Related]  

  • 50. An Intriguing and Important Concept Relevant to Oxidized Low-Density Lipoprotein and Atherogenesis is Still Problematic for its Contribution to the Better Understanding of Clinical Atherosclerosis.
    Yoshida H
    J Atheroscler Thromb; 2018 Oct; 25(10):1007-1008. PubMed ID: 30068830
    [No Abstract]   [Full Text] [Related]  

  • 51. CD4-positive T-lymphocytes can oxidatively modify low density lipoprotein.
    Lamb DJ; Leake DS
    Biochem Soc Trans; 1993 May; 21(2):132S. PubMed ID: 8103001
    [No Abstract]   [Full Text] [Related]  

  • 52. Formation, metabolism and physiologic effects of oxidatively modified low density lipoprotein. Overview.
    Shireman R
    J Nutr; 1996 Apr; 126(4 Suppl):1049S-52S. PubMed ID: 8642430
    [No Abstract]   [Full Text] [Related]  

  • 53. Is low-density lipoprotein hormone-like?
    Jacobs M; Bruckdorfer KR
    Trends Pharmacol Sci; 1988 Jul; 9(7):235-6. PubMed ID: 3247677
    [No Abstract]   [Full Text] [Related]  

  • 54. The oxidation hypothesis of atherosclerosis.
    Rajman I; Kendall M; Cramb R
    Lancet; 1994 Nov; 344(8933):1363-4. PubMed ID: 7968044
    [No Abstract]   [Full Text] [Related]  

  • 55. Proteolytic 'defences' and the accumulation of oxidized polypeptides in cataractogenesis and atherogenesis.
    Dean RT; Dunlop R; Hume P; Rodgers KJ
    Biochem Soc Symp; 2003; (70):135-46. PubMed ID: 14587289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frontiers of atherosclerosis and lipoprotein research. Special issue in memory of Professor Shlomo Eisenberg.
    Isr J Med Sci; 1996 Jun; 32(6):i, 345-508. PubMed ID: 8682638
    [No Abstract]   [Full Text] [Related]  

  • 57. The Loss of a Prominent Scientist: Detlef Schröder.
    Havlas Z
    Chempluschem; 2013 Sep; 78(9):887-889. PubMed ID: 31986745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tribute to Grayce M. Sills: My Colleague, My Friend.
    Smoyak SA
    J Psychosoc Nurs Ment Health Serv; 2016 May; 54(5):13-4. PubMed ID: 27135887
    [No Abstract]   [Full Text] [Related]  

  • 59. Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis.
    Lee CK; Liao CW; Meng SW; Wu WK; Chiang JY; Wu MS
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathophysiology and Medical Treatment of Carotid Artery Stenosis.
    Prasad K
    Int J Angiol; 2015 Sep; 24(3):158-72. PubMed ID: 26417183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.